Bioreactor

Frost & Sullivan Released Report: "The Fourth Revolutionary Wave of Biologics Manufacturing: CDMOs Empower Large-Scale Production of Biologics"

Retrieved on: 
onsdag, maj 29, 2024
Bioprocess, Stainless steel, Fourth, Bioreactor, CGT, ADC, Frost, Research, Biopharmaceutical, CDMO, Fine chemical

Shanghai, China--(Newsfile Corp. - May 29, 2024) - Frost & Sullivan released a report, titled "The Fourth Revolutionary Wave of Biologics Manufacturing: CDMOs Empower Large-Scale Production of Biologics".

Key Points: 
  • Shanghai, China--(Newsfile Corp. - May 29, 2024) - Frost & Sullivan released a report, titled "The Fourth Revolutionary Wave of Biologics Manufacturing: CDMOs Empower Large-Scale Production of Biologics".
  • The global market size of biologics CDMOs has grown significantly from US$13.3 billion in 2018 to US$29.3 billion in 2022.
  • Given the challenges in process development and production for different biologics types, specialized CDMO services for each type have emerged.
  • In the fourth revolutionary wave of biologics manufacturing, leading companies invest heavily in production capacity to remain competitive
    The world's leading CDMOs are ramping up capacities for the large-scale commercial production of biologics.

Donaldson Announces Integrated Lentiviral Vector Manufacturing Platform Development

Retrieved on: 
onsdag, maj 8, 2024
Other Manufacturing, Technology, Research, Other Technology, Manufacturing, Biotechnology, Health, Other Science, Science, RNA virus, RNA, AAV, DNA, Lentivirus, Perfusion, Bioreactor, Donaldson Company, DCI, Clinical trial, Vaccine

Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, announced its Isolere Bio (Isolere) and Univercells Technologies businesses are developing an integrated upstream and downstream platform for viral vector manufacturing.

Key Points: 
  • Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, announced its Isolere Bio (Isolere) and Univercells Technologies businesses are developing an integrated upstream and downstream platform for viral vector manufacturing.
  • The first phase will focus on lentivirus (LV) manufacturing, concentrating on improving recoveries with a scalable process while keeping the manufacturing footprint small.
  • “This manufacturing platform promises to establish a solution that accelerates process development timelines and reduces manufacturing complexity in the production of accessible cell and gene therapies worldwide,” said Andrew Dahlgren, Donaldson Life Sciences president.
  • Mathias Garny, Univercells Technologies’ general manager, said, “scale-X technology is a demonstrated bioreactor platform for rapid process development and scale-up of virus manufacturing.

Fujifilm to Invest Additional $1.2 Billion to Expand its Large-Scale Cell Culture CDMO Business in North Carolina

Retrieved on: 
torsdag, april 11, 2024
Nitrogen oxide, Fujifilm Diosynth Biotechnologies, Solar energy, Monoclonal antibody, Town, Water, Carbon, Growth, CDMO, Environment, Life, Certification, LEED, Bioreactor, Patient, Gold, Fujifilm, Spacecraft, Renewable energy

TOKYO, April 11, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Corporation today announced an investment of $1.2 billion in its Large-Scale Cell Culture CDMO* Business to further expand the planned FUJIFILM Diosynth Biotechnologies end-to-end bio-manufacturing facility in Holly Springs, North Carolina, bringing the total investment in the facility to over $3.2 billion.

Key Points: 
  • TOKYO, April 11, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Corporation today announced an investment of $1.2 billion in its Large-Scale Cell Culture CDMO* Business to further expand the planned FUJIFILM Diosynth Biotechnologies end-to-end bio-manufacturing facility in Holly Springs, North Carolina, bringing the total investment in the facility to over $3.2 billion.
  • The expansion adds significant large-scale production capacity to FUJIFILM Diosynth Biotechnologies’ global network through its United States and Europe manufacturing hubs.
  • The investment will generate an additional 680 jobs by 2031, also bringing the total number of new, highly skilled local jobs to 1400 in Holly Springs.
  • Over the course of the 12-year term of this grant, the project is estimated to grow the state’s economy by $4.7 billion.

Meatable Successfully Hosts First Cultivated Meat Tasting in European Union

Retrieved on: 
onsdag, april 17, 2024
Technology, Retail, Food Tech, Food, Beverage, Singapore Food Agency, Safety, Animal, SFA, CAPEX, Restaurant, European, Michelin, Environment, Bioreactor, Diplomatic rank, Agriculture

Meatable, the innovative food tech company on a mission to deliver cultivated meat at scale, has successfully hosted the first-ever legally approved cultivated meat tasting in the European Union.

Key Points: 
  • Meatable, the innovative food tech company on a mission to deliver cultivated meat at scale, has successfully hosted the first-ever legally approved cultivated meat tasting in the European Union.
  • This landmark event is a groundbreaking milestone for the industry, as Meatable continues to blaze the trail for cultivated meat tasting approvals across the continent and globally on a fast track to commercialization.
  • Krijn de Nood, founder and CEO of Meatable, said: “We are incredibly proud to hold the first official cultivated meat tasting in the European Union, marking a landmark moment for Meatable and our industry.
  • By reducing cell differentiation time, the company can produce high-quality cultivated meat at a significantly reduced cost.

Modular Water Systems and Klir Partner for Water On Demand Pilot Program

Retrieved on: 
tisdag, april 9, 2024
Environment, Technology, Engineering, Other Energy, Utilities, Manufacturing, Green Technology, Energy, Hardware, Bioreactor, MWS, MOU, Software as a service, Software, Acquisition, Environmental quality, Water resources, Water quality, OTC, Water, EVT, MBR, TCEQ, Multimedia, MHP, Renewable energy

(OTC Other: OCLN ), the Clean Water Innovation Hub™, announced today the selection of Klir, Inc. ( www.klir.com ) to support its planned Water On Demand pilot program focusing on mobile home parks (MHP) in the Greater Central Texas Region.

Key Points: 
  • (OTC Other: OCLN ), the Clean Water Innovation Hub™, announced today the selection of Klir, Inc. ( www.klir.com ) to support its planned Water On Demand pilot program focusing on mobile home parks (MHP) in the Greater Central Texas Region.
  • We are committed to supporting OriginClear's Water On Demand pilot program and look forward to delivering seamless, efficient solutions for managing water resources at the local level."
  • We are committed to supporting OriginClear's Water On Demand pilot program and look forward to delivering seamless, efficient solutions for managing water resources at the local level."
  • “We’re very excited that Klir has agreed to join in on our series of planned MWS systems working closely with Enviromaintenance,” said Daniel M. Early, PE, President of Modular Water Systems.

Agilent Brings Great Science to Life at Analytica 2024

Retrieved on: 
torsdag, april 4, 2024
Technology, Chemicals, Plastics, Health, Manufacturing, Batteries, Alternative Energy, Energy, Machinery, Research, Software, Health Technology, Hardware, Science, Semiconductor, Online, Immersion, Automation, Sustainable energy, Advanced Materials, Biotechnology, PFAS, Bioreactor, Environment, Biophysical environment, ICP-OES, MAST, Tissue, Food, ADS, Molecular biology, Laboratory, ICP-MS, Merck Group, Workflow, Agilent Technologies, Water, Chemical substance, BioTek, Fine chemical

Agilent Technologies Inc. (NYSE: A) today announced its participation in Analytica 2024, where it will unveil its latest innovations and transformative workflows.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) today announced its participation in Analytica 2024, where it will unveil its latest innovations and transformative workflows.
  • Analytica, the premier international trade fair for laboratory technology, analysis, and biotechnology, is scheduled to take place from April 9 to 12 in Munich, Germany.
  • Agilent technical experts will be available to share insights into these latest innovations and intuitive workflows.
  • Join us as we bring Great Science to Life!

OriginClear’s Modular Water Systems and Enviromaintenance Partner for Water On Demand Pilot Program

Retrieved on: 
tisdag, mars 26, 2024
Other Natural Resources, Utilities, Energy, Natural Resources, Construction & Property, Urban Planning, Bioreactor, MWS, Partner, MOU, Graphics, Partnership, Environmental quality, Water, Trailer, OTC, EVT, MBR, TCEQ, MHP, Sewage treatment

(OTC Other: OCLN ), the Clean Water Innovation Hub™, announced the signing of a Memorandum of Understanding (MOU) between Modular Water Systems (MWS) and Enviromaintenance of Georgetown, TX to collaborate on sales of standardized systems in the Greater Central Texas Region, from Waco to San Antonio.

Key Points: 
  • (OTC Other: OCLN ), the Clean Water Innovation Hub™, announced the signing of a Memorandum of Understanding (MOU) between Modular Water Systems (MWS) and Enviromaintenance of Georgetown, TX to collaborate on sales of standardized systems in the Greater Central Texas Region, from Waco to San Antonio.
  • The company plans to recommend Modular Water System’s fully integrated, modular wastewater treatment systems to MHPs, thereby providing mobile home park owners an affordable, reliable and efficient way to treat their wastewater.
  • The company plans to recommend MWS’s fully integrated, modular wastewater treatment systems to MHPs, thereby providing mobile home park owners an affordable, reliable and efficient way to treat their wastewater.
  • MWS, a division of OriginClear subsidiary Water On Demand™, manufactures a series of robust and durable wastewater treatment systems and has commercialized highly-standardized systems for MHPs, incorporating either IFAS (Integrated Film Activated Sludge) or MBR (Membrane Bio Reactor) treatment capabilities.

Global Cultured Meat Market Size, Trends, Competitors, and Forecasts Report 2023: By 2040, a Projected 60% of the Meat will be Created from Cells Grown Within Bioreactors and Sold Worldwide - ResearchAndMarkets.com

Retrieved on: 
måndag, mars 25, 2024
Retail, Agriculture, Natural Resources, Food, Beverage, Aleph Farms, Bioreactor, NCI, Meat, Competition, Market, Cell, Bill, Upside Foods, Global Health, Research, Sale, Seafood, DFJ, Silicon, Investment, European, Cargill, Restaurant, Imagination, Geography, Language, Tyson Foods, Fast food

The "The Global Market for Cultured Meat - Market Size, Trends, Competitors, and Forecasts (2023)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The Global Market for Cultured Meat - Market Size, Trends, Competitors, and Forecasts (2023)" report has been added to ResearchAndMarkets.com's offering.
  • By 2040, a projected 60% of the meat will be created from cells grown within bioreactors and sold across grocery stores and restaurants worldwide.
  • Over the next 10 to 20 years, the cultured meat market is projected to act as a major disruptor to the conventional meat market.
  • The main objectives of this cultured meat report are to provide the reader with the following details:
    Global market size for cultured meat, segmented by geography and meat type
    Future market size for the cultured meat, segmented by geography, meat type, and year

Meatable Achieves Landmark Breakthrough In Cultivated Meat Technology, Cuts Production Time To Only 4 Days

Retrieved on: 
torsdag, mars 21, 2024
Supply Chain Management, Retail, Specialty, Food, Beverage, Bioreactor, Meat, Farmer, CAPEX, Cell, Environment, PSC, Differentiable function, Water, Multimedia, Animal, Movement, Agriculture

Meatable , an industry-leading food technology company, today announced that it has reached an important milestone in its efforts to produce cultivated meat at scale.

Key Points: 
  • Meatable , an industry-leading food technology company, today announced that it has reached an important milestone in its efforts to produce cultivated meat at scale.
  • This breakthrough will enable the company to produce cultivated meat significantly faster and at lower costs than industry norms, and is therefore an important step towards the commercialization of Meatable’s technology and large-scale production of cultivated meat products more broadly.
  • View the full release here: https://www.businesswire.com/news/home/20240321679210/en/
    Meatable Achieves Landmark Breakthrough In Cultivated Meat Technology, Cuts Production Time To Only 4 Days (Photo: Business Wire)
    The breakthrough, using Meatable’s core patented Opti-Ox technology, confronts the challenges faced by the cultivated meat industry to produce product fast and efficiently in order to scale to commercial levels.
  • With its process enabling movement from “cell-to-sausage” in only four days, Meatable can produce high-quality cultivated meat at a significantly reduced cost.

Sensorion Reports Full-Year 2023 Financial Results and Business Update

Retrieved on: 
torsdag, mars 14, 2024
Biotechnology, Pharmaceutical, Health, Clinical Trials, Bioreactor, Malignancy, Cell, Chemistry, Patient, Orphan, Good manufacturing practice, Health care, CMC, G&A, Molecular biology, Quality of life, European Medicines Agency, Science, Clinical trial, Cisplatin, Therapy, Hertz, Neoplasm, CIO, Congress, Huber loss, Partnership, Ageing, EMA, Hearing loss, GMP, Cochlea, Biochemistry, Safety, Language, Perilymph, G7, Medication, Control, AAV, PTA, IHC, Pasteur Institute, CDMO, Communication, Genetics, Research, KOL, Ear, POC, FDA, Ototoxicity, GJB2, ABR, CTA, ANSM, Audiogram, Platinum, Investment company, Congenital hearing loss, Pathology, Presbycusis, Hearing, Pharmaceutical industry

Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing loss disorders, today reports full-year 2023 financial results and business update.

Key Points: 
  • Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing loss disorders, today reports full-year 2023 financial results and business update.
  • Nawal Ouzren, Chief Executive Officer of Sensorion, said: “Over the past months, Sensorion has successfully achieved all the major milestones on its roadmap.
  • In the first half of 2023, Sensorion achieved a major development milestone by completing the preclinical package, and successfully producing the GMP dual AAV SENS-501 clinical batches at 200L scale.
  • On April 6, 2023, Sensorion announced the candidate selection for GJB2-GT during its gene therapy focused R&D Day.